MassDevice.com's statistics on the public M&A transaction found that the number of transactions in 2013 was 57, an increase of 39.0% from 41 in 2013. But the real news is the transaction volume: the total valuation of 57 transactions this year is as high as 86.39 billion US dollars, up 504.1% compared with last year's 14.3 billion US dollars. Therefore, it is concluded that the M&A activity in the medical device industry has been extremely active this year. After the decline in the past few years, the number and amount of transactions have climbed to the highs of recent years.
Nearly half of the total transaction volume of $86.39 billion comes from a super-big deal: Medtronic bought Covidien for $43 billion. After excluding the deal, another 56 transactions totaled $43.4 billion, still 203.4% higher than in 2013. In addition, the medical device industry's top 10 M&A transactions this year totaled US$79.6 billion (excluding Medtronic/Kehui, which was US$36.6 billion).
Table 1: Top Ten M&A Transactions in the Medical Device Industry in 2014
Some companies have conducted more than one M&A deal this year:
Medtronic: 6 pens, with a total value of $43.97 billion (excluding Kehui's deal, $965 million)
NGC Medical, $350 million
Sapiens, $200 million
Tyrx, $160 million
Corventis, $150 million
Visualase, $105 million
YT-H706
YT-H706
Shenzhen Sunshine Technology Co.,Ltd , https://www.yatwinsz.com